Microbio is an Australian biotech startup that plans to change the course of pathogen detection. Our novel diagnostic method combines the latest advances in bioinformatics, genomics and molecular microbiology to deliver rapid pathogen detection using qPCR. Developed in collaboration with Australian clinicians, Microbio’s flagship product InfectID-BSI has been designed with clinical decision-making in mind, to… Continue reading Introducing Microbio
Tag: PCR
Microbio appoints Jeff Bryant to drive global commercial strategy
Microbio Ltd, an Australian pathogen detection diagnostics company, is pleased to announce the appointment of Jeff Bryant as its Commercial Director. Mr Bryant will lead the company’s commercial team as it executes its global commercialisation strategy. With his extensive experience in market entry strategy, sales growth, and sales channel development, Mr Bryant brings valuable expertise… Continue reading Microbio appoints Jeff Bryant to drive global commercial strategy
Microbio closes latest investment round after surpassing $3.5m target
Queensland biotechnology scale-up Microbio has closed its latest investment round after surpassing its $3.5 million target. This investment will facilitate Microbio expanding regulatory approval into international markets, having already received clearance for distribution and use in Europe and the UK, with approval in India and South America expected by the end of 2022, and TGA… Continue reading Microbio closes latest investment round after surpassing $3.5m target
Microbio receives clearance to sell InfectID-BSI in UK
Australian biotech scale-up Microbio has received clearance for the sale of its revolutionary InfectID-BSI bloodstream infection test in the United Kingdom. Read more in the media release: 220815_Microbio_receives_clearance_to_sell_in_UK
Microbio’s bloodstream infection test cleared for sale in Europe
Australian biotech scaleup, Microbio is set to break into the European market with its flagship bloodstream infection (BSI) test. Following extensive clinical evaluation trials, the company has been granted a CE Mark, which has opened the door for distribution and use in Europe. Read more in the media release: 220614_Australian_bloodstream_infection_test_cleared_for_sale_in_Europe